GE Healthcare

GE Healthcare is one of the largest medical-equipment companies in the world, operating in imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics. Originally a division of General Electric dating back to 1994 in its modern form, the company was spun off as an independent publicly-traded entity in January 2023 (NASDAQ: GEHC). Market capitalization is approximately $40 billion as of 2026, with annual revenue around $19.7 billion (FY2024) across roughly 51,000 employees in 100+ countries.

The company's product portfolio includes medical imaging (CT scanners, MRI machines, X-ray, mammography, molecular imaging), ultrasound systems for cardiology, OB/GYN, and point-of-care use, patient monitoring solutions for ICU and operating rooms, anesthesia delivery and respiratory care equipment, and pharmaceutical diagnostics including imaging contrast agents. GE Healthcare's installed base of imaging devices is among the largest worldwide, with deep penetration into US, European, and Asian hospital systems.

The Edison platform is GE Healthcare's strategic AI initiative — a unified software framework that brings AI applications directly to the company's imaging hardware. Edison hosts AI applications from GE Healthcare and partner developers, with offerings spanning radiology workflow optimization (auto-protocoling, hanging protocols, worklist prioritization), image quality enhancement (denoising, super-resolution), clinical decision support (lung-nodule detection, cardiac function analysis), radiation-oncology treatment planning (FDA-cleared auto-contouring of tumors and healthy organs on CT and MR scans through its MIM software line), and patient monitoring (early-warning sepsis prediction, respiratory failure prediction). The Edison Health Services cloud extends the platform with managed AI hosting for hospitals. Strategic partnerships span Microsoft Azure, Sutter Health, Mayo Clinic, AWS, and dozens of AI-software companies.